Previous 10 | Next 10 |
Soleno Therapeutics (NASDAQ: SLNO ) +15% . More news on: Soleno Therapeutics, Inc., Proteostasis Therapeutics, Inc., Microbot Medical Inc., Stocks on the move, Read more ...
Gainers: Mirum Pharmaceuticals (NASDAQ: MIRM ) +110% . More news on: Mirum Pharmaceuticals, Inc., Axsome Therapeutics, Inc., The Goldfield Corporation, Stocks on the move, Read more ...
Omeros (OMER) reported positive results for OMS721 or narsoplimab, an anti-MASP-2 antibody that Omeros plans to use in HSCT-associated thrombotic microangiopathy, or HSCT-TMA, a potentially fatal complication of using stem cells to treat hematological malignancies. The treatment achieved 100 d...
When you hear about penny stocks , oftentimes people will refer to technical indicators and momentum first. There are, of course, a catalyst that can be cited as a trigger for a short term move. But, in general, your average day trader looks at things like share volume and technical levels. We ...
Gainers: Protagonist Therapeutics (NASDAQ: PTGX ) +63% . More news on: Protagonist Therapeutics, Inc., Arbutus Biopharma Corporation, Kodiak Sciences Inc., Stocks on the move, Read more ...
Gainers: JanOne (NASDAQ: JAN ) +103% . More news on: JanOne Inc., Sorrento Therapeutics, Inc., The Peck Company Holdings, Inc., Stocks on the move, Read more ...
CymaBay Therapeutics (NASDAQ: CBAY ) -75% on halting trial of seladelpar. More news on: CymaBay Therapeutics, Inc., Adamis Pharmaceuticals Corporation, La Jolla Pharmaceutical Company, Stocks on the move, Read more ...
La Jolla Pharmaceuticals (NASDAQ: LJPC ) -37.3% pre-market following news that it will reassess continued development of LJPC-401 (synthetic human hepcidin), its lead investigational product for the potential treatment of conditions characterized by iron overload, based on recent mixed c...
SAN DIEGO, Nov. 25, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announ...
SAN DIEGO, Nov. 25, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announ...
News, Short Squeeze, Breakout and More Instantly...
La Jolla Pharmaceutical Company Company Name:
LJPC Stock Symbol:
NASDAQ Market:
La Jolla Pharmaceutical Company Website:
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of L...
The biotech investment sector has always been its own market, very distinct from other sectors. So it was no surprise that when most sectors turned slowly upward after the pandemic-inspired crash, Biotech (XBI) rose 164%, exceeding the overall market (SPY) performance by triple digits. Then, a...